Insmed Incorporated
NASDAQInsmed is navigating a rough stretch — a brutal earnings-day selloff, a mounting short position, and a fresh shelf registration filed after the close — all while the Street remains structurally bullish at a price that is nearly half where targets cluster. The week's most important short-term event happened on May 7. Insmed reported Q1 results and the stock fell 26% on the day. It…
Snapshot as of 25 Jun 2026
Insmed is navigating a rough stretch — a brutal earnings-day selloff, a mounting short position, and a fresh shelf registration filed after the close — all while the Street remains structurally bullish at a price that…
Insmed heads into its May 13 Q1 print carrying a bruise that's hard to ignore: the stock fell 26% in a single session on May 7. That drop — the largest recorded in the earnings history data — came after the company…
Insmed Incorporated enters its May 7 Q1 results with a clear tension at its core: the Street is broadly bullish and price targets sit well above where the stock trades, yet short sellers have been quietly rebuilding…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for INSM — free to start on ORTEX.
Sign up for free →Open INSM on ORTEX